Adaptive Biotechnologies (ADPT) X Mentions Statistics 2025

8 700%

1W 300% 1M 100%

Est. daily mentions of Cashtag on X.

Similar companies

Company		X Mentions
	Amgen AMGN	8 42.9%
	Gilead Sciences GILD	22 4.3%
	Inovio Pharmaceuticals INO	11 8.3%
	Anavex Life Sciences AVXL	7 50%
	BridgeBio Pharma BBIO	2 91.7%

Analyzing X Mentions, how is Adaptive Biotechnologies performing compared to its industry peers?

Adaptive Biotechnologies underperforms its industry peers when it comes to X Mentions, ranking in the 1st percentile.

Why should an investor track X mentions?

Investors should track mentions of Adaptive Biotechnologies on X because sudden increases in activity often reflect shifts in retail interest, sentiment, or breaking news. These signals can precede sharp price movements, offering valuable context for timing trades or identifying emerging opportunities.

Sentiment on X

The sentiment score for Adaptive Biotechnologies on X is 57 (out of 100). This is considered neutral.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.